LNC Therapeutics Acquires Exclusive License for Microbes Potentially Related to Obesity

LNC Therapeutics announced on 10/15/18 that it has signed an exclusive license agreement with Cornell University (Ithaca, NY, USA) for its Christensenella patent family.